Why CVS Health Corp. (CVS) Stock Fell 12.5% on Nov 4, 2026
What happened
CVS Health fell 11.46% to $80.93 despite beating Q3 earnings and revenue estimates (Zacks), raising its full-year forecast on health-care benefits and pharmacy gains (Wall Street Journal), and announcing plans to split into two companies (MarketWatch). The sharp decline suggests investors are digesting the strategic breakup announcement or repricing execution and separation risks despite near-term operational strength.
Monitor for details on the breakup timeline, regulatory filings, and management commentary on how the split aligns with competitive dynamics in pharmacy and health benefits; next earnings update (scheduled February 9, 2027, consensus $1.26 EPS) will be critical for assessing operational momentum during transition planning.
Other developments that session
CVS Health Corp. (CVS) reported EPS of $2.09 vs. $1.65 consensus estimate for Q3 FY2026, beating by 26.7% on 2026-11-04.
CVS Health Corp. (CVS) filed a new 8-K on November 4, 2026. The filing content was not detailed in available sources.
CVS reported Q3 EPS of $2.09, beating consensus by $0.47 and growing 31% year-over-year.
Frequently asked questions
Why did CVS Health Corp. (CVS) stock fall on Nov 4, 2026?
CVS Health fell 11.46% to $80.93 despite beating Q3 earnings and revenue estimates (Zacks), raising its full-year forecast on health-care benefits and pharmacy gains (Wall Street Journal), and announcing plans to split into two companies (MarketWatch). The sharp decline suggests investors are digesting the strategic breakup announcement or repricing execution and separation risks despite near-term operational strength.
How much did CVS stock fall on Nov 4, 2026?
CVS fell 12.5% during the Nov 4, 2026 trading session.
